The complexity of Alzheimer's disease: an evolving puzzle

C Ferrari, S Sorbi - Physiological reviews, 2021 - journals.physiology.org
The history of Alzheimer's disease (AD) started in 1907, but we needed to wait until the end
of the century to identify the components of pathological hallmarks and genetic subtypes and …

The future of Alzheimer's disease: the next 10 years

H Hampel, D Prvulovic, S Teipel, F Jessen… - Progress in …, 2011 - Elsevier
Alzheimer's disease (AD) is a fast growing world-wide epidemic. AD is a genetically
complex, slowly progressive, and irreversible neurodegenerative disease of the brain …

Ten challenges of the amyloid hypothesis of Alzheimer's disease

KP Kepp - Journal of Alzheimer's Disease, 2017 - content.iospress.com
The inability to effectively halt or cure Alzheimer's disease (AD), exacerbated by the recent
failures of high-profile clinical trials, emphasizes the urgent need to understand the complex …

Alzheimer's disease

CA Lane, J Hardy, JM Schott - European journal of neurology, 2018 - Wiley Online Library
Alzheimer's disease, the commonest cause of dementia, is a growing global health concern
with huge implications for individuals and society. In this review, current understanding of …

A systemic view of Alzheimer disease—insights from amyloid-β metabolism beyond the brain

J Wang, BJ Gu, CL Masters, YJ Wang - Nature reviews neurology, 2017 - nature.com
Alzheimer disease (AD) is the most common type of dementia, and is currently incurable;
existing treatments for AD produce only a modest amelioration of symptoms. Research into …

Alzheimer disease

DS Knopman, H Amieva, RC Petersen… - Nature reviews Disease …, 2021 - nature.com
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …

Alzheimer's disease: a general introduction and pathomechanism

VH Finder - Journal of Alzheimer's disease, 2010 - content.iospress.com
Alzheimer's disease (AD) is the most common form of dementia, which affects more than 35
million people worldwide with increasing tendency. Satisfying therapies and prevention are …

[HTML][HTML] The genetic landscape of Alzheimer disease: clinical implications and perspectives

C Van Cauwenberghe, C Van Broeckhoven… - Genetics in …, 2016 - nature.com
The search for the genetic factors contributing to Alzheimer disease (AD) has evolved
tremendously throughout the years. It started from the discovery of fully penetrant mutations …

Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia

I Ferrer - Progress in neurobiology, 2012 - Elsevier
Since the description by Alois Alzheimer, more than 50 years have passed during which
senile dementia and pre-senile dementia have been considered Alzheimer disease (AD) on …

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers

C Reitz, R Mayeux - Biochemical pharmacology, 2014 - Elsevier
The global prevalence of dementia is as high as 24 million, and has been predicted to
quadruple by the year 2050. In the US alone, Alzheimer disease (AD)–the most frequent …